Fulgent Genetics, Inc. (FLGT) stock
FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$25.13+0.92 (+3.80%)
Close on Nov 18, 2026Market cap $691.46MP/E –Yield –
Fulgent Genetics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Fulgent Genetics's revenue for the twelve months ending Jun 30, 2026 was $323.93M, up 6.8% year over year. For fiscal 2025 it was $322.67M, up 13.8% from the year before. Over ten years it grew 42.2% a year on average. The highest annual figure on record is $992.58M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $322.67M | +13.8% |
| FY2024 | Dec 31, 2024 | $283.47M | -2.0% |
| FY2023 | Dec 31, 2023 | $289.21M | -53.3% |
| FY2022 | Dec 31, 2022 | $618.97M | -37.6% |
| FY2021 | Dec 31, 2021 | $992.58M | +135.4% |
| FY2020 | Dec 31, 2020 | $421.71M | +1196.5% |
| FY2019 | Dec 31, 2019 | $32.53M | +52.3% |
| FY2018 | Dec 31, 2018 | $21.35M | +14.0% |
| FY2017 | Dec 31, 2017 | $18.73M | +2.5% |
| FY2016 | Dec 31, 2016 | $18.28M | +90.9% |
| FY2015 | Dec 31, 2015 | $9.58M | +649.3% |
| FY2014 | Dec 31, 2014 | $1.28M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $85.39M | +4.4% |
| Q1 FY2026 | Mar 31, 2026 | $71.14M | -3.2% |
| Q4 FY2025 | Dec 31, 2025 | $83.34M | +9.3% |
| Q3 FY2025 | Sep 30, 2025 | $84.07M | +17.2% |
| Q2 FY2025 | Jun 30, 2025 | $81.80M | +15.2% |
| Q1 FY2025 | Mar 31, 2025 | $73.46M | +13.9% |
| Q4 FY2024 | Dec 31, 2024 | $76.21M | +8.1% |
| Q3 FY2024 | Sep 30, 2024 | $71.74M | -15.3% |
| Q2 FY2024 | Jun 30, 2024 | $71.03M | +4.7% |
| Q1 FY2024 | Mar 31, 2024 | $64.49M | -2.5% |
| Q4 FY2023 | Dec 31, 2023 | $70.51M | +4.1% |
| Q3 FY2023 | Sep 30, 2023 | $84.69M | -19.8% |
| Q2 FY2023 | Jun 30, 2023 | $67.85M | -45.9% |
| Q1 FY2023 | Mar 31, 2023 | $66.17M | -79.3% |
| Q4 FY2022 | Dec 31, 2022 | $67.70M | -73.1% |
| Q3 FY2022 | Sep 30, 2022 | $105.66M | -53.6% |
| Q2 FY2022 | Jun 30, 2022 | $125.34M | -18.4% |
| Q1 FY2022 | Mar 31, 2022 | $320.27M | -10.9% |
| Q4 FY2021 | Dec 31, 2021 | $251.67M | -14.7% |
| Q3 FY2021 | Sep 30, 2021 | $227.87M | +124.0% |
| Q2 FY2021 | Jun 30, 2021 | $153.62M | +789.8% |
| Q1 FY2021 | Mar 31, 2021 | $359.43M | +4536.0% |
| Q4 FY2020 | Dec 31, 2020 | $294.98M | +3417.1% |
| Q3 FY2020 | Sep 30, 2020 | $101.72M | +883.0% |
| Q2 FY2020 | Jun 30, 2020 | $17.27M | +105.0% |
| Q1 FY2020 | Mar 31, 2020 | $7.75M | +44.4% |
| Q4 FY2019 | Dec 31, 2019 | $8.39M | +47.8% |
| Q3 FY2019 | Sep 30, 2019 | $10.35M | +83.9% |
| Q2 FY2019 | Jun 30, 2019 | $8.42M | +56.0% |
| Q1 FY2019 | Mar 31, 2019 | $5.37M | +15.4% |
| Q4 FY2018 | Dec 31, 2018 | $5.67M | +32.5% |
| Q3 FY2018 | Sep 30, 2018 | $5.63M | +24.9% |
| Q2 FY2018 | Jun 30, 2018 | $5.40M | +16.4% |
| Q1 FY2018 | Mar 31, 2018 | $4.65M | -12.3% |
| Q4 FY2017 | Dec 31, 2017 | $4.28M | -26.9% |
| Q3 FY2017 | Sep 30, 2017 | $4.50M | -10.1% |
| Q2 FY2017 | Jun 30, 2017 | $4.64M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.31M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.85M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.01M | – |
See a number that looks wrong?